« Previous
Next »
Titles
- OHRP generally conducted its compliance activities independently, but changes would strengthen its independence1
- OHRP should inform potential complainants of how they can seek whistleblower protections: 1
- Older adult housing: future collaborations on housing and health services should include relevant agencies and define outcomes : report to the Ranking Member, Committee on Financial Services, House of Representatives1
- Oncology pharmaceuticals: reproductive toxicity testing and labeling recommendations1
- Oncology therapeutic radiopharmaceuticals: nonclinical studies and labeling recommendations1
- Opioid use disorder: developing depot buprenorphine products for treatment1
- Opioid use disorder: endpoints for demonstrating effectiveness of drugs for treatment1
- Opioid use disorders: HHS needs measures to assess the effectiveness of efforts to expand access to medication-assisted treatment : report to majority leader, U.S. Senate1
- Opioid use in Medicare Part D remains concerning1
- Opioids in Ohio Medicaid: review of extreme use and prescribing1
- Osteoporosis: nonclinical evaluation of drugs intended for treatment1